UC, VA Researchers Awarded Grants to Study Cellular Mechanisms Behind Chronic Illnesses
CINCINNATISix researchers from the University of Cincinnati and Cincinnati Department of Veterans Affairs (VA) Medical Center have been awarded over $4 million in federal research grants to investigate chronic diseases that commonly affect veterans.
These U.S. Department of Veterans Affairs awards, called Merit Review Grants, require that researchers undergo a rigorous peer-review process, similar to that used at the National Institutes of Health (NIH).
Peter Walzer, MD, director of research at the Cincinnati VA and professor of medicine at UC, says these awardswhich will be distributed over three to five yearsare a huge accomplishment for those who earned them as well as the disciplines they represent.
Five of these grants went to PhDs, or basic scientists, as opposed to MDs, which is rare in itself, he says. The national VA research program was developed to attract high-quality physicians; thus, most of the investigatorsabout 70 percentare MDs. Basic researchers must first undergo a competitive process even before they are deemed eligible to submit grants.
In the latest round, 11 grants were submitted and six were funded. Usually, only one in five researchers will receive fundinga 20 percent success rate. It speaks highly of our researchers and the work they are doing in Cincinnati.
Researchers awarded grants include:
· Rupak Banerjee, PhD, College of Engineering
· Melanie Cushion, PhD, Division of Infectious Diseases
· George Deepe, MD, Division of Infectious Diseases
· Dan Hassett, PhD, Department of Molecular Genetics, Biochemistry and Microbiology
· Kenneth Wagner, PhD, Department of Neurology
· Susan Waltz, PhD, Department of Cancer and Cell Biology
Their studies, which range in subject matter from cardiac, pulmonary and infectious diseases to breast cancer and stroke, are looking at the step-by-step cellular development of diseases to find out why they occur and what can be done to prevent them.
All of these researchers have an interest in looking at the pathogenesis of these conditions and using this knowledge to help develop new targets and approaches to treatment and prevention, Walzer says, noting that many of these chronic conditions affect veterans but that this research also applies to the general population.
He adds that this funding creates exciting opportunities for collaboration by university and VA-based faculty that may result in more medical advancement than could be achieved by investigators working alone.
This diverse group of researchers and their specialties truly speak to the expertise present at the VA and at UC, he says. These awards provide a win-win situation for both institutions and create a standard of research excellence for not only Cincinnati but also for the Tristate.
Melanie Cushion, PhD, and Peter Walzer, MD
Related Stories
UC experts present neurology research at national conference
April 17, 2026
University of Cincinnati researchers will present abstracts at the 2026 American Academy of Neurology Annual Meeting April 18 to 22 in Chicago.
AI advances in the liver disease field
April 15, 2026
MASH represents the advanced inflammatory form of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as nonalcoholic fatty liver disease), where fat accumulation in the liver triggers fibrosis and progressive liver injury. According to a recent MedCentral article, more AI-based clinical assessment tools in MASH are needed.
UC Graduate College honors 2026 Graduate Student Research Award recipients during Research + Innovation Week
April 15, 2026
The University of Cincinnati Graduate College is proud to announce the recipients of the 2026 Graduate Student Research Awards, recognizing doctoral students whose research, scholarship, and creative work demonstrate excellence in innovation, impact and interdisciplinarity.